Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 27, 2020
Jun. 29, 2019
Jun. 27, 2020
Jun. 29, 2019
Net sales $ 71,801 $ 119,260 $ 264,351 $ 323,773
Cost of goods sold 68,819 94,470 220,893 261,505
Gross profit 2,982 24,790 43,458 62,268
Selling, general and administrative expenses 15,206 17,931 51,130 51,771
Other loss (income), net 9,364 (1,477) 7,724 (574)
Operating (loss) income (21,588) 8,336 (15,396) 11,071
Interest expense, net 1,710 1,989 5,320 5,739
(Loss) earnings before (benefit from) provision for income taxes (23,298) 6,347 (20,716) 5,332
(Benefit from) provision for income taxes (5,454) 1,510 (4,884) 896
Consolidated net (loss) earnings (17,844) 4,837 (15,832) 4,436
Net loss attributable to non-controlling interest 63 89 286 283
Net (loss) earnings attributable to shareholders $ (17,781) $ 4,926 $ (15,546) $ 4,719
Basic (loss) earnings per share (in dollars per share) $ (2.58) $ 0.71 $ (2.24) $ 0.68
Diluted (loss) earnings per share (in dollars per share) $ (2.58) $ 0.70 $ (2.24) $ 0.67
Weighted average number of shares outstanding (in shares) 6,890 6,928 6,932 6,931
Dilutive effect of stock awards (in shares) 0 152 0 134
Weighted average number of shares assuming dilution (in shares) 6,890 7,080 6,932 7,065